Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Tepotinib(Tepmetko)

Non small cell lung cancer with MET gene exon 14 mutation positive and unresectable progression and recurrence.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：159
Rezurock(Belumosudil mesylate tablets)

iIndicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease .【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：148
Deucravacitinib(Sotyktu)

Deucravacitinib is suitable for treating plaque psoriasis.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：193
Momelotinib(Ojjaara)

Momelotinib is indicated for the treatment of intermediate or high-risk myelofibrosis.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：247
Pirtobrutinib(Jaypirca)

Used for relapsed/refractory mantle cell lymphoma and other B-cell malignancies.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：186
Filgotinib(Jyseleca)

Adult patients with moderate to severe rheumatoid arthritis (RA) who have insufficient or intolerant response to various disease modifying antirheumatic drugs (DMARD).【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：211
Daprodustat(Jesduvroq)

Daprodustat is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：169
Dacomitinib(Vizimpro)

The first-line treatment for metastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21L858R substitution mutation.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：259
Quizartinib(Vanflyta)

Used for the treatment of relapsed or refractory FLT3-ITD mutation positive acute myeloid leukemia.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：145
Valcyte(Valganciclovir)

Valcyte treatment for cytomegalovirus infection.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：250
Vemurafenib(Zelboraf)

Vemurafenib can treat melanoma and Erdheim Chester Disease.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：189
Ceritinib(Zykadia)

Suitable for treating adult patients with metastatic non-small cell lung cancer (NSCLC).【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：155

home page previous 45 45/102 next last page

News

The U.S. FDA approved the combination of Pembrolizumab and Enfortumab vedotin-ejfv for the treatment
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】

Recommended：[list:visits]2025-17-12
Lucius Pharmaceuticals Laos launched lorlatinib, a third-generation targeted drug for lung cancer
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】

Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】

Recommended：[list:visits]2026-06-08
Lao Pharmacies and Manufacturer Direct Shipping: Legal Pathways and Pitfall Guide for Overseas Medi
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】

Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】

Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now available
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】

Recommended：[list:visits]2026-03-08
Laos Lucius, ASEAN Pharmaceuticals (TLPH), and Alliance Pharmaceuticals: Which generic drug manufac
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】

Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in Laos
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】

Recommended：[list:visits]2026-30-07

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More